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Background: Cervical metastasis has a tremendous impact on the prognosis in patients with carcinomas of the
head and neck and the frequency of such spread is greater than 20% for most squamous cell carcinomas. With
emerging evidence, focus is shifting to conservative neck procedures aimed at achieving good shoulder function
without compromising oncologic safety. The purpose of this study was to analyze the pattern of nodal metastasis
in patients presenting with squamous cell carcinoma of buccal mucosa.
Materials and methods: This was a prospective clinical analysis of patients who were histologically diagnosed with
squamous cell carcinoma of the buccal cavity and clinically N1 and had not received treatment anywhere else.
Patients were analyzed for age and sex distribution, tumor staging, location, and metastasis.
Results: The incidence of metastatic lymph node in T4 (n=44) was the highest, that is, level I was 100% (44/44),
level II was 43.18% (19/44), level III was 15.90% (7/44), and level IV was 4.5% (2/44). Level V was free of metastasis.
Among T3 (n=10) lesions, incidence of metastasis in level I was 100% (10/10), level II was 20% (2/10), and level III, IV,
and V were free of metastasis. Among T2 (n=6) lesions, incidence of lymph node metastasis in level I was 100%
(6/6) and all other levels of lymph nodes were found free of metastasis.
Conclusion: Lymphatic spread from carcinoma of the buccal mucosa is low. Involvement of level IV is seen in only
3% of patients. A more conservative approach to the neck in patients with carcinoma of the buccal mucosa is
recommended.
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Squamous cell carcinoma (SCC) in the head and neck
region occurs primarily in the oral cavity and oropharynx
and is generally regarded as a disease of the elderly [1]. In
contrast to other sites of oral cancer, the incidence of the
buccal carcinoma is increasing, especially in younger age
groups [2,3]. The incidence of buccal carcinoma is much
higher in Asia. In Southeast Asia, the disease is the most* Correspondence: rana.majeed@mh-hannover.de
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reproduction in any medium, provided the orcommon form of oral cavity cancer. The higher rate of
buccal carcinoma is likely related to the widespread prac-
tice of betel nut chewing. Betel nut, composed mainly of
the fruit of the Areca Palm and often mixed with tobacco,
is placed along the buccal mucosa to induce a feeling of
euphoria. The anatomical and physiological milking
muscle action predispose to an early invasion and metas-
tasis of buccal carcinoma [4]. Multimodal management of
buccal carcinoma include surgery, radiotherapy, chemo-
therapy, and the combination of the above three. It
depends upon tumor factors such as site, size (T stage),
location, multiplicity, proximity to bone, pathological fea-
tures, histology grade, depth of invasion, and status ofd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ous treatments and medical condition of the patient.
Competence and convenience of the surgeon, economics
and compliance of the patients, and expected complica-
tions also play their role in treatment planning [5]. Ap-
proximately 300 lymph nodes are located in the head and
neck and they comprise 30% of the total 800 lymph nodes
in the human body. Cervical metastasis has a tremendous
impact on the prognosis in patients with carcinomas of
the head and neck and the frequency of such spread is
greater than 20% for most squamous cell carcinomas [6].
Predictive factors of cervical metastasis are primary site,
primary tumor size, degree of differentiation of tumor,
perineural invasion, perivascular invasion, inflammatory
response, and tumor DNA content (ploidy) [7]. It is
described that 49% occult metastasis in cervical lymph
nodes in patients presenting with squamous cell carcin-
oma of buccal mucosa [8]. Level I was the most common
site for nodal metastases (100%), followed by level II
(32%), level III (16%), and level IV (8%) [9]. Despite the
development of multimodal treatment options, the prog-
nosis remains relatively poor. After tongue carcinoma,
the manifestation of occult lymph node metastasis of
buccal carcinoma is observed more often than in any
other cancer of the oral cavity [10]. An overall 5-year
survival rate of 65% is described in the literature, although
the distribution of tumor stages was about the same com-
pared to the preceding 10-year period [11,12]. Better sur-
vival was related to a more aggressive treatment of the
neck even in early tumor stages and to adjuvant radiother-
apy in advanced tumor stages. A considerable number of
patients had to be upstaged after elective neck dissection
due to occult lymph node metastasis. The number of
lymph node metastasis turned out to be of prognostic
value. Only a few investigations have been done into the
metastasis of squamous cell carcinoma of the buccal mu-
cosa. But it is striking that the incidence of cervical lymph
node metastasis from cancer of the buccal mucosa is
significant.
The aim of this study is to analyze our data on the
pattern of nodal metastasis in patients presenting with
squamous cell carcinoma of buccal mucosa, their topo-
graphic distribution in different levels of cervical lymph
nodes to provide grounds for an appropriate and optimal
type of neck dissection required to obtain valid criteria
for therapeutic decision-making in clinical routine.
Materials and methods
The study was approved by the local ethics committee at
the King Edward Medical University Lahore (KEMU-
2008/602). Study subjects were enrolled in a clinical
protocol reviewed and approved by the institutional can-
cer board. Before the beginning of the study, written
informed consent was obtained from each patient.Patients
Patients were enrolled from the King Edward Medical
University, Department of Oral and Maxillofacial Surgery.
Sixty patients with tumor sizes T2 to T4 and clinically
proven N1 neck were evaluated for the presence of metas-
tasis in subsequent levels. All patients were provided
with an informed consent and completed a detailed
questionnaire, which included information on demo-
graphics, smoking and alcohol use, betel nut chewing,
current medications, general health, and dental care
history.
Sample size
The calculated sample size was 60 cases with 95% confi-
dence level, 12% margin of error, and taking expected
percentage of metastasis in level III, that is, 32% in
patients of squamous cell carcinoma of buccal mucosa
undergoing extended supra-omohyoid neck dissection/
selective (levels I to V).
Study including criteria and protocol
Only patients aged 25 to 75 years with squamous cell
carcinoma of buccal mucosa, tumor size T2 to T4 and
clinically involved N1 were included in this study. Poten-
tial participants would have been excluded from the
study because of history of being previously operated,
systemic metastasis, already irradiated, co-morbid medical
conditions resulting in fitness problem for general
anesthesia. The clinical inclusion and exclusion criteria
are shown in Table 1.
All patients provided an informed consent and com-
pleted a detailed questionnaire, which included informa-
tion on demographics, smoking and alcohol use, betel
nut chewing, current medications, general health, and
dental care history.
Data collection
Incisional biopsy proven patients with tumor sizes T2 to
T4, N1, M0 of oral squamous cell carcinoma of buccal
mucosa presenting at the Department of Oral & Maxillo-
facial Surgery, King Edward Medical University, Lahore
were admitted and prepared for surgery. Grading of the
tumor among all patients was done according to the
American Joint Committee on Cancer (AJCC)/UICC
2002 TNM classification. The demographic variables
(that is, name, age, sex, address) will be recorded and
informed consent will be taken.
Resection of the tumor with a safe margin of 1 cm to
1.5 cm was done in all patients. Moreover, neck dissec-
tion was done by one experienced operator in all patients
and the extent of neck dissection was extended supra-
omohyoid/selective (levels I to V). Margins of all resected
specimens of primary tumor and cervical lymph nodes
were marked with silk orientation sutures (Figure 1).
Table 1 Patient’s preoperative demographic data
Inclusion criteria Exclusion criteria




cases of squamous cell carcinoma
of buccal mucosa
Systemic metastasis (detected by
means of chest X-ray, abdominal
ultrasound, and CT scan)
Primary tumor site in oral cavity
is buccal mucosa
Unfit for general anesthesia
Clinical tumor size T2 to T4 Previously irradiated
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silk strings, level III with three silk strings, level IV with
four silk strings, and level V with five silk strings
(Figure 2). The marked specimen along with biopsy form
containing details of history and description of orienta-
tion silk strings was then sent for histopathological
examination in which presence or absence of metastatic
tumor cells was noted in level I to V lymph nodes. The
above information was collected on performa attached as
annexure-I.Statistical analysis
The collected information was transferred to SPSS (Stat-
istical Package for the Social Sciences) version 11.5. The
results will be presented in the form of frequencies and
percentages. Qualitative variables such as levels ofFigure 1 (A) demonstrates the margins of all resected specimens of p
with one silk string, level II with two silk strings, level III with three silk strin
(B) a 51-year-old patient with a squamous cell carcinoma of buccal mucosacervical lymph nodes (levels I, II and III, IV, V) and sex
were presented as percentages and frequencies. Data
were stratified for size of tumor (T2 to T4) to address
effect modifiers. Quantitative variables such as age
were presented as mean ± SD.Results
Sixty patients of squamous cell carcinoma (SCC) of buccal
mucosa were included. There were 75% male patients
(n=45) and 25% female patients (n=15). The male:female
ratio was 3:1. The mean age was 56.55 years ± 5.48. Mini-
mum age was 26 years and maximum was 66 years.
According to T classification most of the cases were of T4
(>4 cm; 73.3%) (n=44), while T3 (>4 cm) lesions were
16.7% (n=10) on second number, and only 10% (n=6)
cases were with T2-sized lesions in our case series
(Table 2).
According to metastatic node, the highest incidence of
histopathologically positive lymph node level was level I
(that is, 66.7%, n=40) followed by positive levels I and II
(that is, 21.7%, n=13), and on the third number was
positive levels I, II, and III (that is, 8.3%, n=5) while only
3.3% (n=2) cases were of positive I, II, III, and IV lymph
node levels. Level V was not positive in any of the case
Table 3.
Between T classification and metastatic node, cross-
tabulation showed that the incidence of metastatic
lymph node in T4 (n=44) was the highest, that is, level I
was 100% (44/44), level II was 43.18% (19/44), level III
was 15.90% (7/44), and level IV was 4.5% (2/44); level Vrimary tumor and cervical lymph nodes. Level I was marked
gs, level IV with four silk strings, and level V with five silk strings,
and clinically proven N1 neck.
Table 3 Metastatic lymph node levels
Frequency Percentage
Level I 40 66.7%
Levels I, II 13 21.7%
Levels I, II, III 5 8.3%
Levels I, II, III, and IV 2 3.3%
Total 60 100%
Figure 2 Metastatic lymph node was the highest, that is, level I
was 100% (44/44), level II was 43.18% (19/44), level III was
15.90% (7/44) and level IV was 3% (2/44). Level V was free of
metastasis.
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dence of metastasis in level I was 100% (10/10), level II
was 20% (2/10), and levels III, IV, and V were free of
metastasis. Among T2 (n=6) lesions, incidence of
lymph node metastasis in level I was 100% (6/6) and
all other levels of lymph nodes were found free of me-
tastasis. So the results of our study coincide with the
study conducted by Y Tzu-Chen et al. (Figure three).Table 2 Baseline characteristics
SCC of buccal mucosa
n=60










≤20 g/d 13 (21.7)
21 to 40 g/d 4 (6.7)
41 to 60 g/d 2 (3.3)
61 to 80 g/d 0 (0)
Unknown 2 (3.3)
Betel nut chewing, n (%)
Yes 52 (86.7)
No 8 (13.3)




Buccal carcinoma commonly presents as a slow-growing
mass on the buccal mucosa. Small lesions tend to be
asymptomatic and are often noted surprisingly on dental
examination. Pain commonly occurs as the lesion
enlarges and ulceration develops. Oral intake may
worsen the pain and lead to malnutrition and dehydra-
tion. Associated symptoms include bleeding, poor den-
ture fit, facial weakness or sensory changes, dysphagia,
odynophagia, and trismus [9].
A detailed medical history is important to determine
the patient’s candidacy for surgery or radiation therapy.
The person often has a history of betel nut chewing,
tobacco, and alcohol use. A history of previous malig-
nancies of the upper aero digestive tract should be ascer-
tained. The appropriate management of the neck in
patients with squamous head and neck cancers is critic-
ally important because the presence of cervical metasta-
sis is the most powerful independent indicator of
locoregional recurrence and overall survival rate. Clinic-
ally undetectable nodal metastasis is the worst possible
scenario for treatment failure. Incidence of neck metas-
tasis in oral SCC is reported to be 34% to 50% [13,14].
Sixty patients with squamous cell carcinoma (SCC)
fulfilling the inclusion criteria who presented in the
Department of Oral & Maxillofacial Surgery in 6 months’
duration of this study were included. Forty-five (75%)
patients were men; 15 (25%) patients were women. The
male:female ratio was 3:1, this shows male predominance
which is in agreement to earlier studies by Amador et al.
[15]. This is probably due to the fact that in Southeast
Asia, snuff dipping and other tobacco-related habits are
more common among men compared to women [16].
However, gender of the patient does not significantly in-
fluence the survival rate. Among the total 60 patients
reported in our study, mean age was 56.55 years. Similar
results have been found by Manuel et al. that SCC is a
disease of middle age from the third to fifth decades [4].
SCC can involve any of the oral subsites and each
primary site of the tumor has its own significance
regarding the behavior of the tumor and its growth
pattern as well as metastasis to cervical lymph nodes.
Buccal mucosa is a very common presenting site of
oral SCC, the higher rates of buccal mucosa carcinoma
in Pakistan are likely related to the widespread practice
Essig et al. World Journal of Surgical Oncology 2012, 10:253 Page 5 of 6
http://www.wjso.com/content/10/1/253of betel nut chewing and snuff dipping. Betel nut,
composed primarily of the fruit of the areca palm and
often mixed with tobacco, is placed along the buccal
mucosa to induce a feeling of euphoria. Buccal carcin-
oma related to betel nut chewing tends to develop at
an earlier age, with most cases occurring between the
ages of 40 and 70 years.
The time of presentation of the cases was very late as
compared to the previous other studies and most of the
cases were T4 73.3% (n=44), followed by T3 lesions
which were 16.7% (n=10), and only 10% (n=6) cases
were T2 lesions in our case series.
In cases of oral SCC, metastasis in the cervical lymph
nodes may occur even in T1 or T2 cases of primary
tumor [17], which is a problem when establishing a
therapeutic regimen. However, a possible predicting fac-
tor has not been established. Although control of the
primary tumor of the oral cavity, particularly in the early
stages, is often achieved, treatment failure frequently
results from recurrence in the cervical lymph nodes,
even among patients who initially present with no clin-
ical evidence of neck disease. In the present study, we
found that the incidence of metastasis in lymph nodes in
T4 (n=44) was the highest, that is level I was 100%
(44/44), level II was 43.18% (19/44), level III was 15.90%
(7/44), and level IV was 4.5% (2/44); level V was free of
any metastatic evidence of the disease. Among T3
(n=10) lesions, incidence of metastasis in level I was
100% (10/10), level II was 20% (2/10), and levels III, IV,
and V were free of metastasis. Among T2 (n=6) lesions
incidence of lymph node metastasis in level I was 100%
(6/6) and all other levels of lymph nodes were found free
of the disease so the above said results coincides with
the results of Tzu-Chen et al. [18].
Also the previous studies support our finding that
tumor size is a predictor of lymph node metastasis
though they propose that tumor thickness is a more
reliable factor [19,20]. This is further explained by Di
Troia [21] who points to difficulty for the tumor emboli
to form in small caliber lymphatics of the superficial
areas, compared with wider lymphatics of deeper tissues
[20]. However, tumor thickness is a radiological or histo-
logical parameter, which cannot be assessed preopera-
tively by clinical examination or biopsy [21-23].
This study was very selective in the sense that we selected
patients only with N1 disease. On ethical grounds, patients
fulfilling the criteria for functional neck dissection were
only selected. There is an important controversy in treat-
ment of neck in cases of oral cavity carcinoma as to
whether to perform radical, modified, or selective neck dis-
section. If selective neck dissection is to be carried out,
which levels need to be removed? Radical neck dissection
produced significant long-term morbidity and deformity
secondary to sacrifice of the spinal accessory nerve,sternocleidomastoid muscle, internal jugular vein (particu-
larly if bilateral), and to the large incisions, skin flaps, and
extent of resection. Shoulder dysfunction, paraesthesia, and
chronic neck and shoulder pain were, and still are, sequelae
of the radical neck dissection.
As the world is moving towards more and more con-
servative and less invasive approaches in treatment of
oral cavity carcinomas, supraomohyoid neck dissection
with the removal of level I, II, and III lymph nodes is
advocated by many surgeons. Supraomohyoid neck dis-
section has been quite satisfactory regarding clearance of
metastatic nodes, in context to 5-year survival and re-
currence rates [24]. We have found that level IV involve-
ment in our study and we recommend removal of level
IV lymph nodes along with the removal of levels I, II,
and III. Many studies support that level IV must also be
removed along with levels I to III. Few studies showed
involvement of level IV lymph nodes <10% of the cases
[6,25]. In another study, level IV involvement was found
to be 7% [7]. We have found the involvement of level IV
nodes in 3% of the cases, so we advocate selective neck
dissection (levels I to IV) in patients presenting with
buccal mucosa carcinoma with N1 neck disease.Conclusion
Lymphatic spread from carcinoma of the buccal mucosa
is low. The most common region with cervical lymph
node metastasis is levels I to III in the ipsilateral neck.
Involvement of level IV is seen in only 3% of patients. A
more conservative approach to the neck in patients with
carcinoma of the buccal mucosa is recommended. This
study provides modern treatment strategies for the man-
agement of squamous cell carcinoma (SCC) of buccal
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